Where Are We Now?
This study makes some interesting points regarding acquired glenoid bone loss in glenohumeral osteoarthritis, and yields valuable insight into the treatment of patients with these conditions. First, it appears that premorbid glenoid version and inclination of osteoarthritic shoulders is not appreciably different than nonpathological shoulders. This suggests that in patients with unilateral disease, the contralateral glenoid version may be used as a ''goal for correction'' during shoulder arthroplasty. Second, this study further validates the authors' glenoid vault model as a technique for determining premorbid glenoid version and inclination. One issue not addressed by the authors was subluxation index in these subjects. Walch et al. [1] proposed that static posterior subluxation of the humeral head may be the first stage of glenohumeral osteoarthritis in patients who eventually develop posterior glenoid bone loss. It is important to note that patients in the Ricchetti study upon which I am commenting here have acquired glenoid bone loss (Walch Type B2 glenoid), an entity distinguishable from congenital glenoid bone loss (Walch Type C; glenoid dysplasia); hence extrapolation of information in this study should not be applied to the latter glenoid type.
Where Do We Need to Go?
This study makes an assumption that patients with posterior glenoid bone loss and subsequent increased glenoid retroversion undergoing shoulder arthroplasty should have their glenoid version corrected to ''normal.'' It is unclear whether correction of excessive retroversion will yield better results compared to patients that have not had version corrected to normal. Additionally, the role of static posterior subluxation of the humeral head contributing to posterior glenoid bone loss needs to be further elucidated.
How Do We Get There?
Studies are needed that correlate correction of pathological glenoid version at the time of shoulder arthroplasty with clinical and radiographic outcomes. Techniques used in this study should be applicable to measuring postoperative glenoid version strengthening the clinical applicability of this study. Finally, the authors could easily assess the subluxation index in these patients, further strengthening our knowledge base on the etiology of glenohumeral arthritis and glenoid bone loss.
